Showing 1 - 10 of 710
suggest that misinformation and related consumer mistakes explain a sizable share of the brand premium for health products …
Persistent link: https://www.econbiz.de/10013050309
We analyze the effects on consumers of an extreme policy experiment -- Napsterizing' pharmaceuticals -- whereby all … associated with greater access to the current stock of pharmaceuticals, future consumers will be harmed by reducing the flow of … new pharmaceuticals to the market. Our estimates of the consumer surpluses at stake are based on the stylized facts …
Persistent link: https://www.econbiz.de/10013212342
Branded pharmaceutical manufacturers frequently offer "copay coupons'" that insulate consumers from cost-sharing, thereby undermining insurers' ability to influence drug utilization. We study the impact of copay coupons on branded drugs first facing generic entry between 2007 and 2010. To...
Persistent link: https://www.econbiz.de/10012981093
are likely to suspect low quality from market price, non-innovator brand and the look of the pharmacy, but none of these … but the signaling effect of price is far from complete, especially for non-innovator brands. The look of the pharmacy, as …
Persistent link: https://www.econbiz.de/10013128895
affects prices to retail pharmacies, plausibly because uncertain quality leads to competition on brand rather than price …
Persistent link: https://www.econbiz.de/10013122879
People have heterogenous life expectancies: women live longer than men, rich people live longer than poor people, and healthy people live longer than sick people. People are also subject to heterogenous out-of-pocket medical expense risk. We construct a rich structural model of saving behavior...
Persistent link: https://www.econbiz.de/10012778297
region. This paper evaluates the effect of this program on the price and utilization of pharmaceutical treatments … potentially negotiate price discounts through their ability to influence the market share of specific treatments. Using data on … the average price and increased the total utilization of prescription drugs by Medicare recipients. Our results further …
Persistent link: https://www.econbiz.de/10012759410
The controversy over whether and how much to charge for health products in the developing world rests, in part, on whether higher prices can increase use, either by targeting distribution to high-use households (a screening effect), or by stimulating use psychologically through a sunk-cost...
Persistent link: https://www.econbiz.de/10012759942
This paper examines the relationship between drug price and drug quality and how it varies across two of the most … standards and price control mechanisms (MES+PC). Through a simple model of adverse selection we model the interaction between … greater incentives to produce high quality drugs. Second, an MES+PC mix reduces the difference in price between the highest …
Persistent link: https://www.econbiz.de/10012768128
agencies and private organizations all conducting investigations into the pricing patterns for generic drugs. Price spikes for … selected old, off-patent drugs have also been widely reported in the media. To place these generic price increases into context …, we construct two chained Laspeyres consumer price indexes (CPIs), using the 2007-2016 IBM MarketScan Commercial Claims …
Persistent link: https://www.econbiz.de/10012865747